Loading institutional data...
Loading institutional data...
Held by 612 of 5,944 reporting institutions (98th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Insufficient data. Current ROIC on all capital: 4%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash of $566M is below short-term debt of $586M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $73.35 today, the market must believe free cash flow compounds 9.5%/yr for a decade (off $553M normalized FCF).
The market's 9.5% is more optimistic than its 9-yr track record.
2-stage DCF · 0.11B shares · net debt $4.2B
mean 1.1% · volatility σ 36% · implied rate exceeded in 3/9 yrs
Central path = implied 9.5%/yr growth; shaded band = ±1σ (36%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend takes 90% of free cash flow — sustainable but with limited headroom. Last year: $381M dividends + $0 buybacks = $381M returned on $424M FCF.
2 consecutive years of dividend increases · 7%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.75B 100.0% | $9.38B 100.0% | $9.21B 100.0% | $10.58B 100.0% | $10.48B 100.0% | $8.47B 100.0% | $9.27B 100.0% | $10.15B 100.0% | $9.55B 100.0% | $9.01B 100.0% |
| Cost of Revenue | $6.91B 78.9% | $7.09B 75.6% | $7.15B 77.6% | $8.44B 79.8% | $7.98B 76.1% | $6.50B 76.7% | $7.04B 75.9% | $7.67B 75.6% | $7.19B 75.3% | $6.65B 73.8% |
| Cost of Products | — | — | — | — | — | — | — | — | $7.09B 74.3% | $6.66B 73.9% |
| Gross Profit | $1.84B 21.1% | $2.29B 24.4% | $2.06B 22.4% | $2.14B 20.2% | $2.50B 23.9% | $1.98B 23.3% | $2.23B 24.1% | $2.48B 24.4% | $2.36B 24.7% | $2.36B 26.2% |
| Research & Development | $255.0M 2.9% | $250.0M 2.7% | $239.0M 2.6% | $264.0M 2.5% | $254.0M 2.4% | $226.0M 2.7% | $234.0M 2.5% | $235.0M 2.3% | $227.0M 2.4% | $223.0M 2.5% |
| Selling, General & Admin | $658.0M 7.5% | $736.0M 7.8% | $727.0M 7.9% | $726.0M 6.9% | $795.0M 7.6% | $654.0M 7.7% | $691.0M 7.5% | $721.0M 7.1% | $729.0M 7.6% | $707.0M 7.8% |
| Operating Income | — | — | — | — | — | — | — | — | $1.53B 16.0% | $1.38B 15.4% |
| Other Income (Expense), net | -$84.0M -1.0% | -$47.0M -0.5% | -$38.0M -0.4% | $6.0M 0.1% | $17.0M 0.2% | -$8.0M -0.1% | -$3.0M -0.0% | $53.0M 0.5% | -$4.0M -0.0% | $4.0M 0.0% |
| Pretax Income | $568.0M 6.5% | $1.08B 11.5% | $1.09B 11.8% | $977.0M 9.2% | $1.08B 10.3% | $530.0M 6.3% | $902.0M 9.7% | $1.31B 12.9% | $1.29B 13.5% | $1.05B 11.6% |
| Income Tax Expense | $93.0M 1.1% | $170.0M 1.8% | $191.0M 2.1% | $181.0M 1.7% | $215.0M 2.1% | $41.0M 0.5% | $140.0M 1.5% | $226.0M 2.2% | -$99.0M -1.0% | $190.0M 2.1% |
| Net Income | $474.0M 5.4% | $905.0M 9.6% | $894.0M 9.7% | $793.0M 7.5% | $857.0M 8.2% | $478.0M 5.6% | $759.0M 8.2% | $1.08B 10.6% | $1.38B 14.5% | $854.0M 9.5% |
| Per Share | ||||||||||
| EPS (Basic) | $4.14 | $7.75 | $7.54 | $6.42 | $6.35 | $3.53 | $5.52 | $7.65 | $9.56 | $5.80 |
| EPS (Diluted) | $4.10 | $7.67 | $7.49 | $6.35 | $6.25 | $3.50 | $5.48 | $7.56 | $9.47 | $5.75 |
| Weighted Avg Shares (Basic) | 114.7M | 116.7M | 118.6M | 123.5M | 134.9M | 135.5M | 137.4M | 141.2M | 144.8M | 147.3M |
| Weighted Avg Shares (Diluted) | 115.6M | 117.9M | 119.4M | 124.9M | 137.1M | 136.5M | 138.5M | 142.9M | 146.1M | 148.4M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 259 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LIN | $230.5B | 33.6× | 20.6× | 6.8× | 3.0% | — | 20.3% | 18.0% | 10.9% | 2.1× | 2,148 |
| BHPLF | $220.3B | — | — | — | — | — | — | — | — | — | 6 |
| SCCO | $162.8B | 37.6× | 21.0× | 12.1× | 17.4% | 60.1% | 32.3% | 39.3% | 24.4% | 0.9× | 791 |
| TX | $107.7B | — | — | — | — | — | — | — | — | — | 139 |
| FCX | $99.7B | — | 12.0× | 3.9× | 1.8% | 28.2% | 8.5% | 11.7% | 7.9% | 1.0× | 1,775 |
| SHW | $91.6B | 36.0× | — | 3.9× | 2.1% | 48.8% | 10.9% | 55.9% | 17.0% | — | 1,610 |
| AEM | $82.8B | — | — | — | — | — | — | — | — | — | 1,066 |
| ECL | $80.5B | 39.2× | 23.7× | 5.0× | 2.2% | 44.5% | 12.9% | 21.2% | 19.5% | 0.3× | 1,619 |
| B | $68.8B | — | — | — | — | — | — | — | — | — | 979 |
| CRH | $66.9B | 18.1× | 10.4× | 1.8× | 5.3% | 36.1% | 10.0% | 15.6% | 9.2% | 2.2× | 9 |
| APD | $65.7B | — | 92.9× | 5.5× | -0.5% | 31.4% | -3.3% | -2.6% | -2.6% | 0.1× | 1,702 |
| VALE | $63.6B | — | — | — | — | — | — | — | — | — | 537 |
| SYAXF | $63.5B | — | — | — | — | — | — | — | — | — | — |
| DD | $61.5B | — | — | 9.0× | 1.9% | 34.5% | 1.3% | 0.6% | 0.6% | — | 1,172 |
| WPM | $55.8B | — | — | — | — | — | — | — | — | — | 809 |
| AU | $44.7B | — | — | — | — | — | — | — | — | — | 537 |
| FNV | $43.7B | — | — | — | — | — | — | — | — | — | 614 |
| STLD | $38.5B | 33.3× | 20.7× | 2.1× | 3.6% | 13.2% | 6.5% | 13.2% | 9.0% | 2.1× | 893 |
| VMC | $37.5B | 35.4× | 17.6× | 4.7× | 7.1% | 27.4% | 13.6% | 12.6% | 8.4% | 1.8× | 981 |
| MLM | $33.4B | 29.5× | 18.6× | 5.4× | 8.6% | 30.7% | 18.5% | 11.3% | 7.4% | 2.6× | 1,022 |
| TCKRF | $32.4B | — | — | — | — | — | — | — | — | — | 8 |
| NTR | $32.1B | — | — | — | — | — | — | — | — | — | 718 |
| AMRZ | $29.2B | 24.7× | 12.1× | 2.5× | 0.9% | 25.7% | 10.0% | 8.9% | 6.5% | 1.9× | 433 |
| GFIOF | $28.7B | — | — | — | — | — | — | — | — | — | 4 |
| PPG | $26.6B | 17.2× | — | 1.7× | 0.2% | 41.3% | 9.9% | 19.8% | 10.8% | — | 1,003 |
| EMN | $8.4B | 17.9× | — | 1.0× | -6.7% | 21.1% | 5.4% | 8.0% | 4.4% | — | 612 |
Peers = companies sharing EMN's sector (Basic Materials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-08-05
No standout strengths flagged.
Where each multiple sits in its own 14-yr range · 57th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 75.6 | 75.9 | 76.7 | 76.1 | 79.8 | 77.6 | 75.6 | 78.9 |
| Gross Profit | 24.4 | 24.1 | 23.3 | 23.9 | 20.2 | 22.4 | 24.4 | 21.1 |
| R&D | 2.3 | 2.5 | 2.7 | 2.4 | 2.5 | 2.6 | 2.7 | 2.9 |
| SG&A | 7.1 | 7.5 | 7.7 | 7.6 | 6.9 | 7.9 | 7.8 | 7.5 |
| Income Tax | 2.2 | 1.5 | 0.5 | 2.1 | 1.7 | 2.1 | 1.8 | 1.1 |
| Net Income | 10.6 | 8.2 | 5.6 | 8.2 | 7.5 | 9.7 | 9.6 | 5.4 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on EMN: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.